Directs the Surgeon General to draft and promulgate rules for the administration of medical activities under Emergency Use Authorization (EUA) for all members of the healthcare community in Louisiana
HB 690 creates new Louisiana law requiring the Surgeon General to promulgate rules governing the administration of medical activities conducted under federal Emergency Use Authorization (EUA). The bill defines EUA, the “healthcare community,” and “health emergency,” and directs the rules to apply broadly to hospitals, clinics, pharmacies, nursing homes, and other healthcare entities. It also makes clear that the rules are intended to apply not only during declared emergencies but also during regular operations when EUA-related medical activities occur.
The bill specifies the minimum content of the rules the Surgeon General must adopt. Those rules must address safe and effective administration of EUA-authorized products, informed consent, adverse-event monitoring and reporting, provider training, access and equity concerns, public transparency, and compliance and enforcement measures. The bill further requires coordination with the Attorney General, the Louisiana State Law Institute, medical and nursing boards, the Louisiana Hospital Association, the Louisiana Board of Pharmacy, and the Louisiana State Medical Society, and it directs the rulemaking process to begin within six months of the act’s effective date.
HB 690 enacts R.S. 40:5.13, adding a new state statutory framework for EUA-related medical activities and giving the Surgeon General explicit authority and responsibility to issue implementing rules under the Administrative Procedure Act. The law does not override federal EUA law, but it requires state-specific guidance that applies across the healthcare sector and may affect hospitals, clinics, pharmacies, nursing homes, and other providers involved in administering EUA products such as therapeutics, vaccines, and diagnostics. It also creates potential compliance obligations and enforcement consequences for healthcare entities once the rules are adopted.
The bill appears to have received generally favorable support overall, as reflected in its final passage in both chambers and the unanimous votes on the conference report and final Senate adoption. At the same time, the earlier House vote to reject Senate amendments suggests that there were substantive differences between the chambers during the legislative process. The final outcome indicates broad agreement on the need for a state framework, even if the precise language required negotiation.
The main points of contention appear to have centered on the scope of state authority over EUA-related medical activities, the breadth of entities covered, and how prescriptive the Surgeon General’s rules should be. Because the bill applies to all members of the healthcare community and reaches both emergency and non-emergency settings, it likely raised concerns among some legislators or stakeholders about regulatory burden, professional autonomy, and the relationship between state rules and federal EUA requirements. The House’s rejection of Senate amendments indicates that the details of the regulatory framework were disputed before a conference report resolved the differences.